Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Antiviral Therapy|August 12, 2017
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovirRoberta Gagliardini, Alessandra Bandera, Mauro Zaccarelli, et al.Viruses|July 2, 2021
Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) DrugsClaudia Minosse, Cesare E M Gruber, Martina Rueca, et al.AIDS Research and Human Retroviruses|August 31, 2002
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failureAndrea Antinori, Mauro Zaccarelli, Antonella Cingolani, et al.Journal of the International AIDS Society|November 14, 2014
Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXACarmela Pinnetti, Lupi Federico, Patrizia Lorenzini, et al.Journal of the International AIDS Society|November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohortCarmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.BMC Infectious Diseases|August 13, 2016
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational studyAlessandra Latini, Massimiliano Fabbiani, Vanni Borghi, et al.Antiviral Therapy|May 17, 2007
The V118I mutation as a marker of advanced HIV infection and disease progressionMauro Zaccarelli, Valerio Tozzi, Patrizia Lorenzini, et al.Antiviral Therapy|June 3, 2010
Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patientsFabiola Ciccosanti, Marco Corazzari, Fabio Soldani, et al.Antiviral Therapy|September 13, 2006
Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparisonAndrea De Luca, Alessandro Cozzi-Lepri, Andrea Antinori, et al.Plos One|October 28, 2017
Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antiviralsGabriella Rozera, Gabriele Fabbri, Patrizia Lorenzini, et al.Pageof 9